INVO Bioscience, Inc.
Hedge Funds Holdings
Last updated:
INVO Bioscience, Inc.‘s stocks are currently a part of 13 hedge funds’ portfolios, which represents 6.36% of the total amount of its stocks outstanding. This makes up a total of 770.88K shares of INVO Bioscience, Inc.. Compared to the previous quarter, the number fell by -41.32% or -542.82K shares fewer. As for the holding position changes, 7.69% (1) of current hedge fund investors increased the number of shares held, 23.08% (3) of current holders sold a part of the shares held, and 15.38% (2) closed the holdings completely. 4 hedge funds are new holders of INVO Bioscience, Inc. stock in Q1 2023, it is 30.77% of total holders.
Hedge funds holding INVO Bioscience (Q4 2016 – Q1 2023)
| Q4 2016 | 1 |
|---|---|
| Q1 2017 | 1 |
| Q2 2017 | 1 |
| Q3 2017 | 1 |
| Q4 2017 | 1 |
| Q1 2018 | 1 |
| Q2 2018 | 1 |
| Q3 2018 | 1 |
| Q4 2018 | 1 |
| Q1 2019 | 0 |
| Q4 2020 | 10 |
| Q1 2021 | 13 |
| Q2 2021 | 14 |
| Q3 2021 | 12 |
| Q4 2021 | 16 |
| Q1 2022 | 19 |
| Q2 2022 | 17 |
| Q3 2022 | 15 |
| Q4 2022 | 19 |
| Q1 2023 | 13 |
Hedge funds changes in INVO Bioscience positions (Q4 2016 – Q1 2023)
| Q4 2016 | 0 | 0 | 0 | 1 | 0 |
|---|---|---|---|---|---|
| Q1 2017 | 0 | 0 | 0 | 0 | 1 |
| Q2 2017 | 0 | 0 | 0 | 0 | 1 |
| Q3 2017 | 0 | 0 | 0 | 0 | 1 |
| Q4 2017 | 0 | 0 | 0 | 0 | 1 |
| Q1 2018 | 0 | 0 | 0 | 0 | 1 |
| Q2 2018 | 0 | 0 | 0 | 0 | 1 |
| Q3 2018 | 0 | 0 | 0 | 0 | 1 |
| Q4 2018 | 1 | 0 | 0 | 0 | 0 |
| Q1 2019 | 0 | 0 | 0 | 1 | -1 |
| Q4 2020 | 10 | 0 | 0 | 0 | 0 |
| Q1 2021 | 7 | 1 | 2 | 4 | -1 |
| Q2 2021 | 5 | 3 | 1 | 4 | 1 |
| Q3 2021 | 0 | 5 | 1 | 2 | 4 |
| Q4 2021 | 6 | 3 | 0 | 2 | 5 |
| Q1 2022 | 5 | 5 | 1 | 2 | 6 |
| Q2 2022 | 2 | 4 | 2 | 4 | 5 |
| Q3 2022 | 1 | 1 | 2 | 3 | 8 |
| Q4 2022 | 8 | 1 | 1 | 3 | 6 |
| Q1 2023 | 4 | 1 | 3 | 2 | 3 |
Hedge funds changes in INVO Bioscience stock options (Q4 2016 – Q1 2023)
| Q4 2016 | 0 | 0 |
|---|---|---|
| Q1 2017 | 0 | 0 |
| Q2 2017 | 0 | 0 |
| Q3 2017 | 0 | 0 |
| Q4 2017 | 0 | 0 |
| Q1 2018 | 0 | 0 |
| Q2 2018 | 0 | 0 |
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 0 | 0 |
| Q4 2021 | 45,000 | 89,000 |
| Q1 2022 | 0 | 72,000 |
| Q2 2022 | 0 | 0 |
| Q3 2022 | 0 | 0 |
| Q4 2022 | 1,697 | 44 |
| Q1 2023 | 2,000 | 0 |
Top 50 hedge fund holders of INVO Bioscience, Inc. (NASDAQ:INVO)
| Hedge fund | Value | Shares owned | Portfolio share |
|---|---|---|---|
| AWM INVESTMENT COMPANY, INC. | 661K | 623.86K | 0.101% |
| VANGUARD GROUP INC | 390K | 367.39K | 0.000% |
| GEODE CAPITAL MANAGEMENT, LLC | 92K | 87.19K | 0.000% |
| BANK OF NEW YORK MELLON CORP | 53K | 50K | 0.000% |
| IEQ CAPITAL, LLC | 53K | 50K | 0.002% |
| CONNORS INVESTOR SERVICES INC | 52K | 49K | 0.007% |
| STATE STREET CORP | 25K | 23.78K | 0.000% |
| EIDELMAN VIRANT CAPITAL | 15K | 14.06K | 0.011% |
| ADVISOR GROUP HOLDINGS, INC. | 15K | 14.48K | 0.000% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 12K | 10.92K | 0.000% |
| NORTHERN TRUST CORP | 12K | 11.40K | 0.000% |
| ROYAL BANK OF CANADA | 11K | 10.77K | 0.000% |
| UBS GROUP AG | 9K | 8.03K | 0.000% |
| GROUP ONE TRADING, L.P. | 2K | 1.6K | 0.000% |
| MORGAN STANLEY | 1K | 843 | 0.000% |
| VIRTU FINANCIAL LLC | 0 | 0 | 0.000% |
| CITADEL ADVISORS LLC Ken Griffin | 0 | 0 | 0.000% |
| BEACON CAPITAL MANAGEMENT, LLC | 0 | 0 | 0.000% |